Dacita K. Suen
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Prospective Clinical Trial on Expanding the Eligibility Criteria for Targeted Axillary Dissection after Neoadjuvant Systemic Therapy in Breast Cancers with Advanced Nodal Disease.
Journal: Annals of surgical oncology
Published: April 21, 2026
The Role of Metacognition, Intolerance of Uncertainty, and Cognitive-Attentional Syndrome in Differentiating Fear of Cancer Recurrence.
Journal: Psycho-oncology
Published: November 01, 2025
Skin-Staining From Superparamagnetic Iron Oxide (SPIO) for Sentinel Lymph Node Sampling-Follow-Up Results From a Randomized Trial.
Journal: World journal of surgery
Published: July 01, 2025
ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors.
Journal: Psychotherapy and psychosomatics
Published: January 18, 2025
Return to work, work productivity loss and activity impairment in Chinese breast cancer survivors 12-month post-surgery: a longitudinal study.
Journal: Frontiers in public health
Published: November 19, 2023
ASO Author Reflections: Pre-Operative Injection of Superparamagnetic Iron Oxide as the Only Localizing Tracer in Sentinel Lymph Node Biopsy in Early Breast Cancer.
Journal: Annals of surgical oncology
Published: February 16, 2023
Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors.
Journal: BMJ open
Published: January 20, 2023
Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
Journal: Annals of surgical oncology
Published: January 12, 2023
Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis.
Journal: Clinical breast cancer
Published: August 23, 2022
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.
Journal: Advances in therapy
Published: August 24, 2021
Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females.
Journal: Journal of community genetics
Published: September 06, 2020
The role of metacognition and its indirect effect through cognitive attentional syndrome on fear of cancer recurrence trajectories: A longitudinal study.
Journal: Psycho-oncology
Published: June 20, 2019
Last Updated: 09/26/2026